Switch View
© BusinessWire
29.10.2025
ISIN: US0162551016
Align Technology, Inc.
ALGN
LISTED
NASDAQ
Align Technology Announces Third Quarter 2025 Financial Results
News Preview
Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the third quarter ("Q3'25"). Q3'25 total reve...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US3847471014
Grail, Inc.
GRAL
LISTED
NASDAQ
GRAIL to Announce Third Quarter 2025 Financial Results
News Preview
Analyst Day 2025 Webcast to Begin at 11:00 a.m. ET on November 13th
MENLO PARK, Calif., Oct. 29, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US9216591084
Vanda Pharmaceuticals Inc
VNDA
LISTED
NASDAQ
Vanda Pharmaceuticals Reports Third Quarter 2025 Financial Results
News Preview
Fanapt® Q3 2025 net product sales increased by 31% to $31.2 million compared to Q3 2024
BysantiTM (milsaperidone) NDA for bipolar I disorder and schizophrenia under review by the FDA; PDUFA target action date of February 21, 2026...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
29.10.2025
ISIN: US0311621009
Amgen Inc
AMGN
LISTED
NASDAQ
AMGEN ANNOUNCES WEBCAST OF 2025 THIRD QUARTER FINANCIAL RESULTS
News Preview
THOUSAND OAKS, Calif., Oct. 29, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its third quarter 2025 financial results on Tuesday, November 4, 2025, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
29.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara announces $75M Royalty Funding Agreement with RTW to Support the Potential Launch of MOLBREEVI* in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
News Preview
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced a $75 million royalty funding agreement with funds managed by RTW Investments, LP (RTW), subject to FDA approval of MOLBREEVI.
“This non-dilutive strategic financing will support the U.S. launch of MOLBREEVI, assum...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: CA60255C8850
Mind Medicine (MindMed) Inc
MNMD
LISTED
NASDAQ
Mind Medicine (MindMed) Inc. Announces Proposed Public Offering
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it intends to offer and sell, subject to market conditions, common shares and, to certain investors, pre-funded warrants to purchase comm...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US04963C2098
AtriCure Inc
ATRC
LISTED
NASDAQ
AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025
News Preview
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced third quarter 2025 financial results.
“Our third quarter results demonstrate strong execution and patient focus across the business. We...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US23285D1090
Cytek Biosciences Inc
CTKB
LISTED
NASDAQ
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
News Preview
Cytek has launched a two-part research support initiative to make cell analysis more accessible....
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US0162551016
Align Technology, Inc.
ALGN
LISTED
NASDAQ
Align Technology Announces ClinCheck® Live Plan That Automates Doctor-Ready Initial Invisalign® Treatment Plan in Minutes
News Preview
Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software, today announced ClinCheck® Live Plan, a new feature in its Invisalign® digital treatment planning that automates the generation of in...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US71742Q1067
Phibro Animal Health Corp
PAHC
LISTED
NASDAQ
Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results
News Preview
Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its first quarter financial results on Wednesday, November 5, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, November 6, 2025, at 9:00 AM Eastern Time.
Interested parties are invited to listen to the conference call and view...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US0162551016
Align Technology, Inc.
ALGN
LISTED
NASDAQ
Align Technology Announces New Innovations for iTero™ Digital Solutions, a Comprehensive Ecosystem That Includes Intraoral Scanners and Integrated Software Tools That Enhance the Chairside Patient Experience
News Preview
Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software, today announced a series of new product innovations for iTero™ Digital Solutions, a comprehensive ecosystem that includes intraoral s...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: IE00BFY8C754
STERIS plc
STE
LISTED
NYSE
STERIS Announces Dividend of $0.63 per share
News Preview
DUBLIN, IRELAND, Oct. 29, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.63 per share. The dividend is payable on December 18, 2025, to shareholders of record at the close of business on November 18, 2025. ...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
29.10.2025
ISIN: US75062E1064
Rafael Holdings Inc
RFL
LISTED
NYSE
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
News Preview
Cyclo Therapeutics’ TransportNPC™ Phase 3 clinical trial for Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is continuing at the recommendation of the Data Monitoring Committee (DMC) following their review of prespecified safety and efficacy date at 48 weeks...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US29089Q1058
Emergent BioSolutions Inc
EBS
LISTED
NYSE
Emergent BioSolutions Reports Third Quarter 2025 Financial Results
News Preview
GAITHERSBURG, Md., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US87918A1051
Teladoc Health Inc
TDOC
LISTED
NYSE
Teladoc Health Reports Third Quarter 2025 Results
News Preview
NEW YORK, NY, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended September 30, 2025 (“Third Quarter 2025”). Unless otherwise noted, percentage and other changes are relative to the three months ended September 30, 2024 (“Third Quarter...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US00091E1091
Absci Corp
ABSI
LISTED
NASDAQ
Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025
News Preview
VANCOUVER, Wash. and NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Absci (Nasdaq: ABSI), a clinical-stage biotech company advancing breakthrough therapeutics with generative AI, today announced the company will report business updates and financial and operating results for the third quarter 2025 after market close on Wednesday, November 12, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US56400P2011
MannKind Corporation
MNKD
LISTED
NASDAQ
MannKind Corporation to Hold 2025 Third Quarter Financial Results Conference Call on November 5, 2025
News Preview
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), announced today that its third quarter 2025 financial results will be released before the market opens on November 5, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US68375N1037
OPKO Health Inc
OPK
LISTED
TLV
OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results
News Preview
Conference call begins at 4:30 p.m. Eastern time today Conference call begins at 4:30 p.m. Eastern time today...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: JP3546800008
Terumo Corporation
45430
LISTED
XJPX
Geisinger and Terumo Neuro Advance Stroke Education and Neurovascular Innovation in Recognition of World Stroke Day 2025
News Preview
Collaboration Highlights Minimally Invasive Neurovascular Stroke Treatment and Expands Public Awareness on Early Recognition and Access to Care
DANVILLE, Pa. and ALISO VIEJO, Calif., Oct. 29, 2025 /PRNewswire/ -- In honor...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
LEVI & KORSINSKY ISSUES CORRECTION: Securities Fraud Class Action Against Hims & Hers Health, Inc.
News Preview
NEW YORK, Oct. 29, 2025 /PRNewswire/ -- A securities fraud class action lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS) is pending. The lawsuit was filed by Glancy Prongay & Murray LLP. Previous press releases stated incorrectly that Levi & Korsinsky filed the case. This press release makes that...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US2528281080
Dianthus Therapeutics Inc
DNTH
LISTED
NASDAQ
Dianthus Therapeutics Highlights New Claseprubart Data Presented During 2025 AANEM Annual Meeting
News Preview
Positive data from Phase 2 MaGic trial presented for claseprubart in generalized Myasthenia Gravis, including new open-label extension data further supporting potential for 300mg/2mL Q4W dosing...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: SE0002148817
Hansa Biopharma AB
HNSA
LISTED
STO
Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results
News Preview
LUND, Sweden, Oct. 29, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host a virtual event featuring two distinguished transplant surgeons; Professor Robert Montgomery from NYU Langone Transplant Institute and Professor Matthew Cooper from the Medical Colleg...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: SE0002148817
Hansa Biopharma AB
HNSA
LISTED
STO
Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results
News Preview
LUND, Sweden, Oct. 29, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host a virtual event featuring two distinguished transplant surgeons; Professor Robert Montgomery from NYU Langone Transplant Institute and Professor Matthew Cooper from the Medical Colleg...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US1897631057
Co-Diagnostics Inc
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
News Preview
SALT LAKE CITY, Oct. 29, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the closing of its previously announced offering of 12,727,272 shares of...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.10.2025
ISIN: US4618741098
eXoZymes Inc
EXOZ
LISTED
NASDAQ
CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference
News Preview
LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 29, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - announced that CEO, Michael Heltzen, will present at the Spartan Capital Securities Inv...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: BE0003739530
UCB SA
UCB
LISTED
EURONEXT
UCB opens applications for 2026 UCB Myasthenia Gravis Scholarship™
News Preview
ATLANTA, Oct. 29, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced the opening of applications for the second annual UCB U.S. Myasthenia Gravis Scholarship™, supporting individuals impacted by myasthenia gravis (MG) including patients, caregivers, and family members who are pursuing f...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: IE00BGH1M568
Perrigo Company PLC
PRGO
LISTED
NYSE
Perrigo Announces Quarterly Dividend
News Preview
DUBLIN, Oct. 29, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of consumer health products, today announced that its Board of Directors declared a quarterly dividend of $0.290 per share, payable on December 16, 2025, to shareholders of record on November 28, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US88165K1016
Tevogen Bio Holdings Inc.
TVGN
LISTED
NASDAQ
Tevogen Senior Management Engages with Business and Community Leaders and Highlights Recent Progress
News Preview
WARREN, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), in ongoing community, industry, and academic engagements, has continued to underscore its biopharma model centered on sustainability and patient affordability, highlighting the Company’s significant progress toward making precision m...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US44975P1030
I-Mab
IMAB
LISTED
NASDAQ
I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform
News Preview
New corporate brand reflects strategic transformation to a global biotech platform accelerating access to innovative medicines for patients worldwide
Strategy centers on broadening access to global capital and innovation through a planned Hong Kong initial public offering (IPO), and holding dual...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.10.2025
ISIN: CA0717341071
Bausch Health Companies Inc
BHC
LISTED
TSX
Bausch Health Announces Third Quarter 2025 Results
News Preview
Third Quarter Consolidated Revenues of $2.68 billion, up 7% on a Reported basis and 5% on an Organic (non-GAAP)1 basis over the prior year periodGAAP Net Income Attributable to Bausch Health of $179 million and GAAP Net Income of $181 millionConsolidated Adjusted EBITDA Attributable to Bausch Health (non-GAAP)1 of $986 million, including an $81 mil...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Molina Healthcare
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Molina To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $75,000 in Molina between February 5...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly announces more than $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the United States
News Preview
Company plans to create 100 manufacturing jobs and up to 1,000 construction jobs
INDIANAPOLIS, Oct. 29, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today a planned investment of more than $1.2 billion to expand and modernize its Lilly del Ca...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In LifeMD To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $75,000 in LifeMD between May 7, 202...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Cytokinetics To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $75,000 in Cytokinetics betwee...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US1920051067
Codexis Inc
CDXS
LISTED
NASDAQ
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing
News Preview
REDWOOD CITY, Calif., Oct. 29, 2025 /PRNewswire/ -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, and Nitto Denko Avecia, Inc. a leading contract development and manufacturing organization (CDMO) specializing in oligonucleotide thera...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US1920051067
Codexis Inc
CDXS
LISTED
NASDAQ
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing
News Preview
REDWOOD CITY, Calif., Oct. 29, 2025 /PRNewswire/ -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, and Nitto Denko Avecia, Inc. a leading contract development and manufacturing organization (CDMO) specializing in oligonucleotide thera...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US09061G1013
BioMarin Pharmaceutical Inc
BMRN
LISTED
NASDAQ
FDA Accepts BioMarin's PALYNZIQ® (pegvaliase-pqpz) Supplemental Biologics License Application for Priority Review to Expand Use to Adolescents Aged 12-17 with Phenylketonuria
News Preview
Application based on positive results from Phase 3 PEGASUS study, which demonstrated statistically significant blood phenylalanine (Phe) lowering compared to diet alone
FDA PDUFA target action date of Feb. 28, 2026...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US88025U1097
10X Genomics Inc
TXG
LISTED
NASDAQ
10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research
News Preview
New plate-based multiplexing unlocks ultra high-sample and cell-throughput single cell analysis to empower a broad range of studies
PLEASANTON, Calif., Oct. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology,...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
t:slim X2™ Insulin Pump Now Available with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States
News Preview
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced that the t:slim X2 insulin pump, featuring Control-IQ+ automated insulin delivery (AID) technology, is now available with Abbott’s FreeStyle Libre 3 Plus continuous glucose monitoring (CGM) sensor integration in the United States.* This...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US98978V1035
Zoetis Inc
ZTS
LISTED
NYSE
Zoetis Receives European Commission Marketing Authorization for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
News Preview
Zoetis Inc. today announced that the European Commission has granted the company marketing authorization for Portela® (relfovetmab), making it the first monoclonal antibody (mAb) therapy with a three-month dosing interval approved for the alleviation of pain associated with osteoarthritis (OA) in cats.
Designed to provide three months of OA pain...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US0327241065
AnaptysBio Inc
ANAB
LISTED
NASDAQ
Anaptys Announces New Positive Phase 2b Trial Results for Rosnilimab in Rheumatoid Arthritis at ACR Late-Breaking Oral Presentation
News Preview
SAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced late-breaking data from the robust, global 424-patient Phase 2b trial of rosnilimab, a selective and potent pathogenic T cell depleter, in rheumatoid arthrit...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
AbbVie Announces Positive Topline Results from Phase 3 Pivotal Studies Evaluating Upadacitinib (RINVOQ®) in Adults and Adolescents with Vitiligo
News Preview
In two replicate Phase 3 studies, upadacitinib (RINVOQ
®
) achieved the co-primary endpoints of 50% reduction in Total Vitiligo Area Scoring Index (T-VASI 50) fr...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US7665596034
Rigel Pharmaceuticals, Inc.
RIGL
LISTED
NASDAQ
Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update
News Preview
SOUTH SAN FRANCISCO, Calif., Oct. 29, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its third quarter 2025 financial results after market close on Tuesday, November 4, 2025. Rigel senior management will follow the announcement with a live conference call and w...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Johnson & Johnson announces first head-to-head study comparing IMAAVY™ with an alternative FcRn blocker in generalized myasthenia gravis (gMG) at AANEM Annual Meeting
News Preview
The EPIC study will evaluate treatment with IMAAVY™ versus efgartigimod in adults with gMG and will include a treatment-switch arm
The Company also announced new data from the pivotal Vibrance-MG study in which pediatric patients receiving treatment with IMAAVY...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US1241551027
Butterfly Network Inc
BFLY
LISTED
NYSE
Butterfly Network to Participate at UBS Global Healthcare Conference 2025
News Preview
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that Joseph DeVivo, President, Chief Executive Officer & Chairman and Megan Carlson, Senior Vice President & Interim Chief Financial Officer will participate in a firesi...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US70387R4039
PAVmed, Inc.
PAVM
LISTED
NASDAQ
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025
News Preview
Conference Call and Webcast at 8:30 AM Eastern Time
NEW YORK, Oct. 29, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq:...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US44975P1030
I-Mab
IMAB
LISTED
NASDAQ
I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform
News Preview
ROCKVILLE, Md., Oct. 29, 2025 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (NovaBridge or the Company) today announced that it has changed its corporate name from I-Mab to NovaBridge Biosciences. The change was overwhelmingly approved by shareholders at the Company’s Extraordinary General Meeting held on October 24, 2025, and by the Company’s Board...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US55279B3015
Lite Strategy, Inc.
LITS
LISTED
NASDAQ
Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation to Active Capital Market Operations
News Preview
Lite Strategy Announces $25M Share Repurchase Program, Shifting From Initial Litecoin Accumulation to Active Capital Market Operations...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US9026731029
UFP Technologies Inc
UFPT
LISTED
NASDAQ
UFP Technologies to Report Third Quarter 2025 Financial Results on November 3, 2025
News Preview
Conference Call Scheduled for November 4th at 8:30 AM ET Conference Call Scheduled for November 4th at 8:30 AM ET...
Themefolio
Profiler
Peergroup
© Newsfile
29.10.2025
ISIN: US29415V1098
Envoy Medical, Inc.
COCH
LISTED
NASDAQ
Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant
News Preview
The Company looks to build on its recent momentum - receiving FDA approval to expand its pivotal clinical trial into the second and final stageWhite Bear Lake, Minnesota--(Newsfile Corp. - October 29, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions,...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US70465T1079
PDS Biotechnology Corp
PDSB
LISTED
NASDAQ
PDS Biotech to Seek Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer
News Preview
Company aims to shorten time frame to make PDS0101 available to patients with HPV16-positive head and neck cancer, projected to be the most dominant type of head and neck cancer in the US by mid 2030s...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US0044685008
Achieve Life Sciences, Inc.
ACHV
LISTED
NASDAQ
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025
News Preview
SEATTLE and VANCOUVER, British Columbia, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced it will report its third quarter...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US75901B1070
Regenxbio Inc
RGNX
LISTED
NASDAQ
REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2025 Financial Results and Operational Highlights
News Preview
ROCKVILLE, Md., Oct. 29, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Thursday, November 6, at 8:00 a.m. ET to discuss its financial results for the third quarter ended September 30, 2025, and operational highlights.
Listeners can regist...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: CH1384053976
NLS Pharmaceutics AG
NLSP
LISTED
NASDAQ
NLS Pharmaceutics and Kadimastem Highlight Continued BIRD Foundation Support for ITOL-102 Diabetes Program Following Merger
News Preview
ZURICH, Oct. 29, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP) ("NLS" or the "Company"), a biopharmaceutical company focused on developing innovative therapies for central nervous system and neurodegenerative disorders, and Kadimastem Ltd. (TASE: KDST) ("Kadimastem"), a clinical-stage cell therapy co...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: BE0003739530
UCB SA
UCB
LISTED
EURONEXT
UCB to unveil new data for RYSTIGGO® (rozanolixizumab-noli) and ZILBRYSQ®(zilucoplan) for gMG at the 2025 AANEM Annual Meeting and MGFA Scientific Session
News Preview
UCB will showcase 18 abstracts, including an oral presentation, demonstrating continued commitment to advancing targeted treatments for generalized myasthenia gravis (gMG).
Presentations include new post hoc analyses considering corticosteroid dose tapering during treatment with RYSTIGGO® (rozan...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US52490G1022
Legend Biotech Corp
LEGN
LISTED
NASDAQ
Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results
News Preview
SOMERSET, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Wednesday, November 12, 2025, to review third quarter 2025 results....
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US4622221004
Ionis Pharmaceuticals Inc
IONS
LISTED
NASDAQ
Ionis reports third quarter 2025 financial results and highlights progress on key programs
News Preview
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) (the “Company”) today reported financial results and provided key updates for the third quarter ended September 30, 2025.
"The third quarter was a watershed moment for Ionis, as we made important progress advancing our Ionis-owned medicines. With two independent launches now underway, and two more antic...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck and Eisai Provide Update on Phase 3 LEAP-012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eisai today announced results from the Phase 3 LEAP-012 trial evaluating KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, plus LENVIMA® (lenvatinib), the orally available multiple receptor tyrosine kinase inhibitor (TKI) discovered by Eisai, in combination with trans...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
European Commission Approves KEYTRUDA® (pembrolizumab) as Part of a Treatment Regimen for Adults with Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Expressing PD-L1 (CPS >1)
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Commission (EC) has approved KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, as monotherapy for the treatment of resectable locally advanced head and neck squamous cell carcinoma (LA-HNSCC) as neoadjuvant treatment, continued as adjuvan...
Themefolio
Profiler
Peergroup
© EQS Newswire
29.10.2025
ISIN: US4525EP1011
Immunic Inc
IMUX
LISTED
NASDAQ
Immunic to Participate in Industry and Investor Conferences in November
News Preview
Immunic to Participate in Industry and Investor Conferences in November
NEW YORK, October 29, 2025 – Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following industry and inve......
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
